The School of Internal Medicine and the Division of Hematology would like to congratulate Dr. John Phillips, PhD and Dr. Charles Parker, MD, both Professors in the Division of Hematology...
Researchers at U of U Health and Cardiff University made a discovery that could lead to what some are calling a universal cancer killer. Featuring Dr. John Phillips (Professor, Hematology).
One staff member from the Department of Internal Medicine will be highlighted monthly as part of our "From the Desk Of" staff recognition initiative. This month's featured staff member is...
Dr. John Phillips (Professor, Hematology) and a team of researchers from Cardiff University have discovered a possible immune therapy using the CRISPR method that could treat many forms of cancer.
Headlines are talking about a new one-size-fits-all type of cancer treatment. Are these claims real or are they just hype? Dr. John Phillips, (Professor, Hematology) at University of Utah Health...
Researchers at Cardiff University have discovered a new type of killer T-cell that offers hope of a “one-size fits all” cancer therapy. Featuring research by Colin Farrell (Lab Specialist, Hematology)...
The International Chronic Myeloid Leukemia Foundation (iCMLf) has awarded the prestigious Rowley Prize to Michael Deininger, MD, PhD, with a formal presentation of the prize taking place earlier in September.
The Utah Center for Bleeding & Clotting Disorders (UCBCD) is committed to providing a comprehensive medical home with state-of-the-art treatment, family-centered education and ground-breaking research to children, adolescents, and adults...
Researchers at Huntsman Cancer Institute at the University of Utah discovered in laboratory studies that an experimental drug called selinexor may block a crucial survival pathway exploited by myelofibrosis cells.
We are pleased to announce a request for postdoctoral applications on the T32 Hematology Training Grant. The application deadline is July 15, 2019. The application details are enclosed. Please contact...